This study is about testing a treatment called LTP001. It has two parts: Part A is for healthy people, and Part B is for people with PAH (Pulmonary Arterial Hypertension), a type of high blood pressure that affects the lungs and heart. The study checks if the treatment is safe and how the body processes it in healthy people. For those with PAH, it also checks if it works well.

• The study has specific criteria for who can join, like being healthy or having PAH.
• Participants in Part A must be healthy and cannot have certain heart issues. In Part B, participants must have PAH.
• There are potential risks like reactions to the treatment, and participants must follow guidelines, like using birth control.

This study is important because it helps researchers understand if LTP001 is a safe and effective treatment for PAH. If you are interested in joining, it's essential to meet the study's criteria and be aware of the potential risks and requirements.